Late bacterial endocarditis after percutaneous atrial septal defect closure

Makiko Nishioka1, Kenji Hoshino1, Shinya Ugaki2

  • 1Department of Pediatric Cardiology, Saitama Children's Medical Center, Saitama330-8777, Japan.

Insights

Infective endocarditis after percutaneous atrial septal defect closure is rare in children. This case highlights a late-stage infection in an 11-year-old girl due to incomplete device endothelialisation.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Infectious Diseases

Background:

  • Percutaneous closure of atrial septal defects (ASDs) is a common alternative to surgery.
  • Infective endocarditis is a known complication of cardiac occluding devices.
  • Late-stage endocarditis following pediatric ASD device closure is exceptionally rare.

Purpose of the Study:

  • To report a rare case of late-stage bacterial endocarditis in a child after percutaneous ASD closure.
  • To emphasize the importance of considering device-related complications even in pediatric patients.

Main Methods:

  • Case report of an 11-year-old girl.
  • Review of clinical presentation, diagnostic workup, and management.
  • Focus on the timeline of endocarditis development post-procedure.

Main Results:

  • The patient developed late-stage bacterial endocarditis.
  • The complication was linked to incomplete endothelialisation of the closure device.
  • This highlights a rare but serious potential adverse event.

Conclusions:

  • Late-stage infective endocarditis can occur following percutaneous ASD closure in children.
  • Incomplete endothelialisation may be a contributing factor.
  • Vigilance for device-related infections is crucial in pediatric cardiology.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
45
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
31
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
33
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
53
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
58